Safety and efficacy of silibinin in patients with brain metastases after SRS: SUSTAIN trial

Authors
Category Primary study
JournalRadiotherapy and Oncology
Year 2023
This article has no abstract
Epistemonikos ID: d67680cfa5a3ac4713416aaa874f3f94904b7bb3
First added on: Feb 16, 2025